Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

DSIP

Emideltide, DSIP nonapeptide, Delta sleep-inducing peptide

Quick Stats
Studies 458
Trials 82
Recruiting NA INTERVENTIONAL NCT03321201

Cauterization Versus fibrin Glue for Conjunctival Autografting in Primary Pterygium Surgery

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

Pterygium is a noncancerous growth of the conjunctival tissue over the cornea. It is a progressive disease that may lead to visual impairment in advanced stages, as well as restriction of ocular motility, chronic inflammation and cosmetic concerns. Surgical removal is the treatment of choice, but recurrence of pterygium is a frequent problem. In this randomized controlled cauterization will be compared with fibrin glue for conjunctival autografting in primary pterygium surgery.

Interventions

Name: Cauterization
Type: PROCEDURE
Description: To ensure the stability of the graft during cuttings, four sealing wraps will be installed, which will be removed after cauterisation is completed. Autograft and conjunctiva will be approximated by surgical forceps and will be cauterized using a bipolar cutter (Erbe ICC 50) with a force 1-3 / 20. Forceps will be released slowly to prevent elevation of the graft. The same procedure will be performed 10 times until graft is well firmed. Graft stability will be checked up with a sponge and additional cauterization will be preformed if needed.
Name: Fibrin glue
Type: PROCEDURE
Description: Fiber adhesive (Tissel 1 mL kit4-iu) will be prepared according to manufacturer's instructions. Preparation time will be approximately 10-15 min per kit. Once mixed the fibrin glue is usable up to 4 h. For the purpose of the study preparation of the fibrin glue will be performed by a nurse.

Primary Outcomes

Measure: Recurrence of pterygium
TimeFrame: 180 days
Description: Any re-growth of tissue from the area of excision across the limbus onto the cornea.

Trial Information

NCT ID

NCT03321201

Status

Recruiting

Study Type

INTERVENTIONAL

Phases

NA

Sponsor

University of Split, School of Medicine

Last Updated

December 15, 2025